
Bruker ( ($BRKR) ) has shared an update. On November 13, 2026, Bruker’s board approved expanding the board by one seat to 12 directors and appointed Eicke Latz, MD PhD,
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| BRKR | Bruker | 60.62 | 19.68 | 48.08% |
| Name | Price | % Change | |
|---|---|---|---|
| $60.62 | +48.08% |

Bruker ( ($BRKR) ) has shared an update. On November 13, 2026, Bruker’s board approved expanding the board by one seat to 12 directors and appointed Eicke Latz, MD PhD,

Bruker (BRKR) Corporation announced that its Board of Directors is adding Eicke Latz, MD PhD to serve on its board of directors, effective as of January 1, 2027. Professor Eicke

Bruker Corporation (($BRKR)) has held its Q3 earnings call. Read on for the main highlights of the call. Bruker Corporation’s earnings call had a predominantly positive tone, led by sharp

An announcement from Bruker ( ($BRKR) ) is now available. Effective July 1, 2026, Bruker completed a reorganization intended to streamline its structure and support decision-making, accountability, customer focus and

Stifel analyst Daniel Arias raised the firm’s price target on Bruker (BRKR) to $60 from $50 and keeps a Hold rating on the shares. Published first on TheFly – the

Citi analyst Patrick Donnelly raised the firm’s price target on Bruker (BRKR) to $64 from $53 and keeps a Neutral rating on the shares. Published first on TheFly – the

Goldman Sachs raised the firm’s price target on Bruker (BRKR) to $55 from $50 and keeps a Sell rating on the shares. The company’s Q3 revenue topped estimates, though the

Reports Q3 revenue $874M, consensus $865.19M. Frank Laukien, Bruker’s (BRKR) President and CEO, commented: “Bruker drives significant advances in post-genomic drug discovery and disease biology research, from proteoforms to glycobiology,

Sees FY26 organic revenue growth 1%-2% Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read

Bruker Corporation (BRKR) is scheduled to report 3rd quarter earnings on 11/04/2026, before the market opens. Regarding Q3 estimates, Wall Street analysts expect Bruker Corporation to post earnings of $0.42
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | Nov 10, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| hold | Reiterated | Nov 5, 2026 | ||||
| hold | Reiterated | Nov 5, 2026 | ||||
| hold | Reiterated | Nov 5, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| sell | Reiterated | Nov 4, 2026 | ||||
| hold | Reiterated | Oct 13, 2026 | ||||
| buy | Reiterated | Aug 5, 2026 | ||||
| buy | Reiterated | Aug 5, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Feb 16, 2027TBA | $9.41B | $0.77 | $1.00B | 2.62 | -56.04 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.